IndraLab
Statements
YOD1 inhibits cell migration. 2 / 2
|
2
reach
"However, research on YOD1 in renal cancer is scarce, highlighting the need for investigations into its role and potential as a therapeutic target in this type of carcinoma.In this study, we first conducted an unbiased RNAi screen targeting OTU deubiquitinating enzymes, which revealed that YOD1 deficiency significantly enhances cell migration."